Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
February 29 2024 - 3:05PM
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq:
ASRT), a specialty pharmaceutical company that acquires,
commercializes and develops safe and effective therapies that make
a difference in the lives of patients, today announced that it will
release fourth quarter and full year 2023 financial results on
Monday, March 11, 2024, after the market close. Following the
release of its financial results, Assertio’s management will host a
live webcast of the earnings conference call at 4:30 p.m. Eastern
Time.
To access the live webcast, conference call information, and
other materials, please visit Assertio’s investor relations website
at http://investor.assertiotx.com/overview/default.aspx. Please
connect at least 10 minutes prior to the live webcast to ensure
adequate time for any software download that may be needed to
access the webcast. For those wishing to join by telephone only,
please dial +1-646-968-2525. The call ID is 9752695.
A webcast replay of the call will be available approximately two
hours after the call on Assertio’s investor website.
About AssertioAssertio is a specialty
pharmaceutical company that acquires, commercializes and develops
safe and effective therapies that make a difference in the lives of
patients. Utilizing a proprietary digital-focused commercialization
approach we can promote products across multiple therapeutic
categories. We strive to lead by example, embrace change, and make
a positive impact in our community while creating better
experiences for our employees, partners and shareholders. To learn
more about Assertio, visit www.assertiotx.com.
Investor Contact Matt KrepsDarrow Associates
Investor
Relations+1-214-597-8200mkreps@darrowir.com
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From May 2024 to Jun 2024
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Jun 2023 to Jun 2024